2019
DOI: 10.1080/01443615.2019.1606184
|View full text |Cite
|
Sign up to set email alerts
|

Study of effects of mifepristone on full-term pregnancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 8 publications
2
4
0
Order By: Relevance
“…We found that women who underwent outpatient cervical ripening with mifepristone had the same rate of Bishop score improvement as women in the inpatient group at 24 h (1 (1–2) vs. 1 (1–2), P = 0.416) and 48 h (3 (2–4) vs. 3 (1–4), P = 0.527). This Bishop score improvement was the same as or slightly lower than that reported in other studies [25] , [26] , [27] , [30] , [31] , [32] , [33] , [34] , [35] , [36] .…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…We found that women who underwent outpatient cervical ripening with mifepristone had the same rate of Bishop score improvement as women in the inpatient group at 24 h (1 (1–2) vs. 1 (1–2), P = 0.416) and 48 h (3 (2–4) vs. 3 (1–4), P = 0.527). This Bishop score improvement was the same as or slightly lower than that reported in other studies [25] , [26] , [27] , [30] , [31] , [32] , [33] , [34] , [35] , [36] .…”
Section: Discussionsupporting
confidence: 86%
“…The frequent use of these additional preinduction methods was due to the need to achieve a high degree of cervical ripening (8 points on the Bishop scale) in accordance with our local protocol. A similar frequency of additional preinduction methods was reported by Sharma et al (73.3 % of dinoprostone gel) [27] and Wing et al (67.0 % of misoprostol) [29] . Sujithra et al reported a lower frequency of dinoprostone gel use (32 %); however, in every fifth case, it was reused twice [35] .…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…Meanwhile, Mifepristone causes softening and dilatation of the human pregnant cervix, resulting in increased uterine activity, so that the intrauterine residues can be eliminated from the body. [ 14 , 15 ]…”
Section: Introductionmentioning
confidence: 99%
“…Meanwhile, Mifepristone causes softening and dilatation of the human pregnant cervix, resulting in increased uterine activity, so that the intrauterine residues can be eliminated from the body. [14,15] In estrogen-progesterone sequential therapy, estrogen attaches to the receptor and causes hyperplasia of the endometrial vasculature and proliferation of glands cells, which fixes the endometrium. Furthermore, estrogen improves the sensitivity of the uterine smooth muscle to oxytocin, which strengthens the contraction of the uterine smooth muscle and induces residual pregnancy tissue stripping from the uterine wall.…”
Section: Introductionmentioning
confidence: 99%